131 related articles for article (PubMed ID: 22235796)
1. Serum neopterin, sialic acid and nitric oxide levels in dogs with malignant mammary tumours.
Tascene N; Kısmalı G; Vural S; Karagul H; Sel T
Vet Comp Oncol; 2012 Jun; 10(2):155-9. PubMed ID: 22235796
[TBL] [Abstract][Full Text] [Related]
2. Serum neopterin levels in female dogs with malignant mammary tumours.
Szczubiał M; Dąbrowski R; Łopuszyński W
Vet Comp Oncol; 2014 Jun; 12(2):143-8. PubMed ID: 22882538
[TBL] [Abstract][Full Text] [Related]
3. Changes in serum neopterin and C-reactive protein concentrations in female dogs with mammary gland tumours.
Szczubiał M; Dabrowski R; Łopuszyński W; Bochniarz M; Krawczyk M
Pol J Vet Sci; 2018 Dec; 21(4):691-696. PubMed ID: 30605283
[TBL] [Abstract][Full Text] [Related]
4. Sialic acid and sialyltransferase activity in serum and tissues of dogs with mammary tumors.
Paltrinieri S; Rossi G; Meregalli A; Stefanello D; Pecile A; Moretti P; Rondena M
Vet Pathol; 2012 Jul; 49(4):669-81. PubMed ID: 21427240
[TBL] [Abstract][Full Text] [Related]
5. Role of steroid hormones and prolactin in canine mammary cancer.
Queiroga FL; Pérez-Alenza MD; Silvan G; Peña L; Lopes C; Illera JC
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):181-7. PubMed ID: 15862964
[TBL] [Abstract][Full Text] [Related]
6. Total serum sialic acid is a general disease marker rather than a specific tumour marker in dogs.
Thougaard AV; Hellmén E; Jensen AL
Zentralbl Veterinarmed A; 1998 Oct; 45(8):471-9. PubMed ID: 9838859
[TBL] [Abstract][Full Text] [Related]
7. Expression and significance of PTEN in canine mammary gland tumours.
Qiu C; Lin D; Wang J; Wang L
Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-8 as a prognostic serum marker in canine mammary gland neoplasias.
Gelaleti GB; Jardim BV; Leonel C; Moschetta MG; Zuccari DA
Vet Immunol Immunopathol; 2012 Apr; 146(2):106-12. PubMed ID: 22405680
[TBL] [Abstract][Full Text] [Related]
9. Serum and Tissue Steroid Hormone Levels in Canine Mammary Tumours: Clinical and Prognostic Implications.
Queiroga FL; Pérez-Alenza D; González-Gil A; Silván G; Peña L; Illera JC
Reprod Domest Anim; 2015 Oct; 50(5):858-65. PubMed ID: 26332137
[TBL] [Abstract][Full Text] [Related]
10. Correlation between alpha 1-acid glycoprotein and total sialic acid in serum from dogs with tumours.
Thougaard AV; Hellmén E; Pedersen HD; Jensen AL
Zentralbl Veterinarmed A; 1999 May; 46(4):231-7. PubMed ID: 10399482
[TBL] [Abstract][Full Text] [Related]
11. Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene.
Hsu WL; Huang HM; Liao JW; Wong ML; Chang SC
Vet J; 2009 Apr; 180(1):116-23. PubMed ID: 18061495
[TBL] [Abstract][Full Text] [Related]
12. Prolactin binding in benign and malignant mammary tissue of female dogs.
Rutteman GR; Willekes-Koolschijn N; Bevers MM; Van der Gugten AA; Misdorp W
Anticancer Res; 1986; 6(4):829-35. PubMed ID: 3019223
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of tissue and serum HER2 and MUC1 in canine mammary cancer.
Campos LC; Silva JO; Santos FS; Araújo MR; Lavalle GE; Ferreira E; Cassali GD
J Vet Diagn Invest; 2015 Jul; 27(4):531-5. PubMed ID: 26179096
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
15. Clinical and prognostic implications of serum and tissue prolactin levels in canine mammary tumours.
Queiroga FL; Pérez-Alenza MD; González Gil A; Silvan G; Peña L; Illera JC
Vet Rec; 2014 Oct; 175(16):403. PubMed ID: 25096592
[TBL] [Abstract][Full Text] [Related]
16. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours.
Ferreira E; Bertagnolli AC; Cavalcanti MF; Schmitt FC; Cassali GD
Vet Comp Oncol; 2009 Dec; 7(4):230-5. PubMed ID: 19891693
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
[TBL] [Abstract][Full Text] [Related]
18. Hormonal background of canine and feline mammary tumours.
Rutteman GR; Misdorp W
J Reprod Fertil Suppl; 1993; 47():483-7. PubMed ID: 8229967
[TBL] [Abstract][Full Text] [Related]
19. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
Gama A; Gärtner F; Alves A; Schmitt F
Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
